文献速递乳腺癌

50岁及以下接受保乳治疗的女性中乳腺X线摄影联合超声或磁共振成像筛查乳腺癌

Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.
PubMed 文献 · JAMA Oncol · 2017-01-01

这项多中心前瞻性非随机研究纳入754例初诊年龄≤50岁且接受保乳治疗的乳腺癌女性,进行3次年度乳腺X线摄影、超声和磁共振成像(MRI)筛查。乳腺X线摄影联合MRI的癌症检出率(每1000例8.2 vs 4.4,P=0.003)和敏感性(100% vs 53%,P=0.01)高于单独乳腺X线摄影;联合超声的检出率也高于单独乳腺X线摄影(每1000例6.8 vs 4.4,P=0.03),但特异性低于单独乳腺X线摄影(87%或88% vs 96%,P<0.001)。

要点

  • 保乳治疗后≤50岁女性中,乳腺X线摄影联合MRI的癌症检出率高于单独乳腺X线摄影(每1000例8.2 vs 4.4)。
  • 乳腺X线摄影联合MRI的敏感性高于单独乳腺X线摄影(100% vs 53%)。
  • 联合MRI或超声的特异性低于单独乳腺X线摄影(87%或88% vs 96%)。

核心结论

  • 在50岁或更年轻的保乳治疗女性中,将MRI加入年度乳腺X线摄影筛查可提高早期但生物学侵袭性强的乳腺癌的检出,且特异性可接受。
  • 该研究结果可为保乳治疗后筛查方法的患者决策提供信息。

研究设计与样本

  • 多中心、前瞻性、非随机研究,于2010年12月1日至2016年1月31日在6家学术机构开展。
  • 纳入754例初诊年龄≤50岁且接受保乳治疗的乳腺癌女性;参考标准为病理学与12个月随访的组合。

主要发现

  • 共754例女性接受了2065次乳腺X线摄影、超声和MRI筛查,诊断17例癌症。
  • 检出的癌症多数(17例中的13例[76%])为0期或1期。
  • 乳腺X线摄影联合MRI的总体癌症检出率高于单独乳腺X线摄影(每1000例8.2 vs 4.4,P=0.003),敏感性也高于单独乳腺X线摄影(100% vs 53%,P=0.01)。
  • 加入超声后,癌症检出率高于单独乳腺X线摄影(每1000例6.8 vs 4.4,P=0.03)。
  • 乳腺X线摄影联合MRI或超声的特异性低于单独乳腺X线摄影(87%或88% vs 96%,P<0.001)。

关键数值与推荐

  • 乳腺X线摄影联合MRI的癌症检出率为每1000例8.2,单独乳腺X线摄影为每1000例4.4(P=0.003)。
  • 乳腺X线摄影联合MRI的敏感性为100%,单独乳腺X线摄影为53%(P=0.01)。
  • 乳腺X线摄影联合超声的癌症检出率为每1000例6.8,单独乳腺X线摄影为每1000例4.4(P=0.03)。
  • 乳腺X线摄影联合MRI或超声的特异性分别为87%或88%,单独乳腺X线摄影为96%(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Younger women (aged ≤50 years) who underwent breast conservation therapy may benefit from breast magnetic resonance imaging (MRI) screening as an adjunct to mammography. OBJECTIVE: To prospectively determine the cancer yield and tumor characteristics of combined mammography with MRI or ultrasonography screening in women who underwent breast conservation therapy for breast cancers and who were 50 years or younger at initial diagnosis. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, prospective, nonrandomized study was conducted from December 1, 2010, to January 31, 2016, at 6 academic institutions. Seven hundred fifty-four women who were 50 years or younger at initial diagnosis and who had undergone breast conservation therapy for breast cancer were recruited to participate in the study. Reference standard was defined as a combination of pathology and 12-month follow-up. INTERVENTIONS: Participants underwent 3 annual MRI screenings of the conserved and contralateral breasts in addition to mammography and ultrasonography, with independent readings. MAIN OUTCOMES AND MEASURES: Cancer detection rate, sensitivity, specificity, interval cancer rate, and characteristics of detected cancers. RESULTS: A total of 754 women underwent 2065 mammograms, ultrasonography, and MRI screenings. Seventeen cancers were diagnosed, and most of the detected cancers (13 of 17 [76%]) were stage 0 or stage 1. Overall cancer detection rate (8.2 vs 4.4 per 1000; P = .003) or sensitivity (100% vs 53%; P = .01) of mammography with MRI was higher than that of mammography alone. After the addition of ultrasonography, the cancer detection rate was higher than that by mammography alone (6.8 vs 4.4 per 1000; P = .03). The specificity of mammography with MRI or ultrasonography was lower than that by mammography alone (87% or 88% vs 96%; P < .001). No interval cancer was found. CONCLUSIONS AND RELEVANCE: After breast conservation therapy in women 50 years or younger, the addition of MRI to annual mammography screening improves detection of early-stage but biologically aggressive breast cancers at acceptable specificity. Results from this study can inform patient decision making on screening methods after breast conservation therapy.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Cho N, Han W, Han BK, et al. Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy. JAMA Oncol. 2017. PMID: 28655029. doi:10.1001/jamaoncol.2017.1256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。